HEALWELL Receives Regulatory Approval from Overseas Investment Office of New Zealand to Acquire Orion Health

Core Viewpoint - HEALWELL AI Inc. has received regulatory approval from the Overseas Investment Office of New Zealand to acquire Orion Health Holdings Limited for NZD$175 million, with a potential earnout of up to NZD$25 million, enhancing its capabilities in healthcare AI and preventative care [2][4][6]. Group 1: Acquisition Details - The acquisition involves HEALWELL acquiring all ordinary shares of Orion Health as per a share purchase agreement dated December 16, 2024 [2][6]. - The total consideration for the acquisition is NZD$175 million, plus a performance-based earnout of up to NZD$25 million [2][3]. - The transaction is expected to close on or before April 1, 2025, following the completion of the closing process [4][6]. Group 2: Strategic Implications - Orion Health is a leader in healthcare technology with over 70 customers in 11 countries and approximately 400 team members, which will significantly expand HEALWELL's market presence [3][6]. - The acquisition will provide HEALWELL access to over 150 million covered lives globally, enhancing its mission of early disease detection [3][6]. - The combined capabilities of HEALWELL and Orion Health are expected to create substantial revenue and cost synergies, particularly in public sector healthcare [3][6]. Group 3: Company Background - HEALWELL is focused on preventative care and aims to improve healthcare outcomes through early disease detection using advanced AI technology [8]. - Orion Health specializes in healthcare information exchange and intelligence platforms, contributing to improved healthcare navigation and interoperability [9].